A startup developing a one-time treatment that is intended to rewind the clock on dying cells announced a major influx of funding.
Life Biosciences, a startup co-founded by Harvard biologist David Sinclair, has raised an …
More pharma dealmaking; FDA’s proposed budget; Takeda ends partnership; and more
Welcome back to another edition of Endpoints Weekly. Two of the year’s major oncology conferences are coming up soon: AACR starting April 17, and ASCO


